Maven Securities LTD Aldeyra Therapeutics, Inc. Transaction History

Maven Securities LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$7.94 - $11.31 $794,000 - $1.13 Million	-100,000 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$10.44 - $14.85 $1.02 Million - $1.45 Million	97,333 Added 3649.53%	100,000 $1.14 Million
Q1 2021 May 17, 2021	BUY	$6.53 - $14.42 $17,415 - $38,458	2,667 New	2,667 $32,000
Q4 2018 Feb 14, 2019	SELL	$7.26 - $13.29 $526,088 - $963,046	-72,464 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$6.8 - $14.35 $492,755 - $1.04 Million	72,464 New	72,464 $989,000

117

36.4M

196K

142K

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $280M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

Stay updated on Maven Securities LTD with notifications on news.